Cancer

March 24, 2022

Berlin named interim leader of Hematology and Oncology

Jordan Berlin, MD, has been appointed interim leader of Vanderbilt’s Division of Hematology and Oncology in the Department of Medicine.

By Tom Wilemon
March 22, 2022

VUMC’s Pietenpol, Shyr named AACR Fellows

Vanderbilt’s Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

By Tom Wilemon
P. Brent Ferrell, MD, is part of a multidisciplinary team studying new approaches to understand and treat cancer.
March 17, 2022

Ferrell lands Mark Foundation for Cancer Research award

Vanderbilt’s Brent Ferrell, MD, is one of the recipients a 2022 Endeavor Award from the The Mark Foundation for Cancer Research.

By Tom Wilemon
March 15, 2022

Improving care for gynecologic cancer

To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines.

By Emily Stembridge
March 10, 2022

Bots boost liver cancer outcome

Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients.

By Leah Mann 
As an 11-year cancer survivor, Lori Martin, BSN, MBA, RT(R), knows firsthand the importance of colorectal cancer screening.
March 9, 2022

Martin shares colorectal cancer story, urges early detection

Vanderbilt Wilson County Hospital’s Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer.

By Tom Wilemon
March 7, 2022

Study finds World Trade Center responders at higher risk for blood cancer-associated mutations

A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease
By Tom Wilemon
February 24, 2022

Melanoma treatment response

Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found.
By Sarah E. Glass
February 17, 2022

Park named director of Vanderbilt-Ingram Cancer Center

Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.
By John Howser
February 17, 2022

Grant to support Haake’s research on kidney cancer

Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.
By Tom Wilemon
February 16, 2022

Yale surgery chair to discuss cancer’s ‘on’ switch at next Discovery Lecture

Renowned surgical oncologist and clinician scientist Nita Ahuja, MD, MBA, chair of the Department of Surgery at Yale School of Medicine, will deliver the next web-based Discovery Lecture.
By Leigh MacMillan
February 3, 2022

Children’s Hospital patients get creative for Vanderbilt Men’s Basketball team as part of Coaches vs. Cancer

By Christina Echegaray
February 3, 2022

Osterman plays key role in major oncology EHR initiative

Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.
By Tom Wilemon
1 … 19 20 21 22 23 … 72